132 filings
Page 3 of 7
8-K
u8aajwgz
21 Aug 08
Lotus Pharmaceuticals Announces Second Quarter 2008 Results
12:00am
424B3
zd3p1sl 02s34itw
25 Jul 08
Prospectus supplement
12:00am
EFFECT
i2igp3w 52ufcply
25 Jul 08
Notice of effectiveness
12:00am
CORRESP
fllf2r1qpfiu9yl3jt
23 Jul 08
Correspondence with SEC
12:00am
8-K
her8l3 6d
17 Jul 08
Entry into a Material Definitive Agreement
12:00am
UPLOAD
k2k671 udzu
2 Jul 08
Letter from SEC
12:00am
UPLOAD
mkyp1s
23 Jun 08
Letter from SEC
12:00am
S-1/A
j4s6mhbb9iq4p jbvxnj
20 Jun 08
IPO registration (amended)
12:00am
EFFECT
ourvx9l
17 Jun 08
Notice of effectiveness
12:00am
POS AM
bt75i
16 Jun 08
Prospectus update (post-effective amendment)
12:00am
UPLOAD
wwq10s
3 Jun 08
Letter from SEC
12:00am
8-K
r1ykg1
30 May 08
Lotus Pharmaceuticals Inc Q1 Earnings Conference Call
12:00am
8-K
tzh mwswl
30 May 08
Lotus Pharmaceuticals, Inc. Obtains Patent and Exclusive Production Rights to Laevo-Bambutero Asthma Treatment
12:00am
8-K
f6b p3k7naymd
22 May 08
Results of Operations and Financial Condition
12:00am
10-Q
mcqhb13uaui64anyn9
20 May 08
Quarterly report
12:00am
NT 10-Q
d0vyg a3ojqds2
16 May 08
Notice of late quarterly filing
12:00am
CORRESP
yofdp1nw 779k
13 May 08
Correspondence with SEC
12:00am
S-1
q281olmg4
13 May 08
IPO registration
12:00am